CD4 and rheumatoid arthritis: Thus, it would be valuable to test the effect of TNFR2 blockade on Tregs and other CD4+ T cell subpopulations and on the levels of cytokines they produce to potentially uncover biological mechanisms that may help develop novel therapeutic strategies to treat RA or other autoimmune diseases.